Large-scale testing (Phase 3)Study completedNCT02006888
What this trial is testing
The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery
Who this might be right for
InflammationCataracts
ICON Bioscience Inc 394